Xiaoting Yu
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
-
- Cancer Immunotherapy and Biomarkers
Papers in ⓘ
-
- Cancer-related molecular mechanisms research 5
- MicroRNA in disease regulation 4
- Aging 1
- Co-authors
- Guoqiang Chen (3 shared papers)Qian Zhao (2 shared papers)Qianqian Yin (2 shared papers)Ci-Xiang Zhou (2 shared papers)Ming He (2 shared papers)Jianrong He (2 shared papers)Yongjun Liang (1 shared paper)Qiuyu Wang (1 shared paper)
- Journals
- International Journal of Biological Macromolecules (2 papers)Oncotarget (2 papers)Cell Death and Disease (2 papers)Clinical Epigenetics (1 paper)Scientific Reports (1 paper)
- Partner nations
- ChinaUnited StatesThailand
In The Last Decade
Xiaoting Yu
41 papers receiving 892 citations
Peers
Comparison fields: 5 of 95
- Cancer Research 317
- Oncology 198
- Molecular Biology 423
- Immunology 107
- Renewable Energy, Sustainability and the Environment 81
Countries citing papers authored by Xiaoting Yu
This map shows the geographic impact of Xiaoting Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoting Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoting Yu more than expected).
Fields of papers citing papers by Xiaoting Yu
This network shows the impact of papers produced by Xiaoting Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoting Yu. The network helps show where Xiaoting Yu may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaoting Yu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 43 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 169 | |
| 2 | 2017 | 82 | |
| 3 | 2020 | 63 | |
| 4 | 2015 | 56 | |
| 5 | 2017 | 42 | |
| 6 | 2015 | 42 | |
| 7 | 2021 | 41 | |
| 8 | Clinical significance of programmed death ligand-1 (PD-L1) in colorectal serrated adenocarcinoma. | 2015 | 35 |
| 9 | 2021 | 34 | |
| 10 | 2017 | 31 | |
| 11 | 2021 | 29 | |
| 12 | 2017 | 28 | |
| 13 | 2023 | 24 | |
| 14 | 2017 | 24 | |
| 15 | 2021 | 20 | |
| 16 | 2021 | 17 | |
| 17 | Histology subtypes and polyp size are associated with synchronous colorectal carcinoma of colorectal serrated polyps: a study of 499 serrated polyps. | 2015 | 17 |
| 18 | 2020 | 15 | |
| 19 | 2021 | 13 | |
| 20 | 2015 | 13 |
About Xiaoting Yu
Xiaoting Yu is a scholar working on Cancer Research, Aging, Immunology and Allergy, Molecular Biology and Geriatrics and Gerontology, having authored 43 papers that have together received 900 indexed citations. Recurring topics across this work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (5 papers), Cancer-related molecular mechanisms research (5 papers), RNA Research and Splicing (4 papers), Electrocatalysts for Energy Conversion (4 papers), RNA modifications and cancer (4 papers), MicroRNA in disease regulation (4 papers), Fuel Cells and Related Materials (4 papers) and Circular RNAs in diseases (3 papers). The work is most often cited by research in Cancer Research (317 citations), Oncology (198 citations), Molecular Biology (423 citations), Immunology (107 citations) and Renewable Energy, Sustainability and the Environment (81 citations). Xiaoting Yu has collaborated with scholars based in China, United States and Thailand. Frequent co-authors include Guoqiang Chen, Qian Zhao, Qianqian Yin, Ci-Xiang Zhou, Ming He, Jianrong He, Yongjun Liang, Qiuyu Wang, Rui Lin and Zhixian Hao. Their work appears in journals such as International Journal of Biological Macromolecules, Oncotarget, Cell Death and Disease, Clinical Epigenetics and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.